ScripEli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec
Generics BulletinLupin has pressed on ‘at-risk’ with the launch of the first generic version of Johnson & Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) 2.5mg tablets, with litigation ongoing over
Generics BulletinLupin and Sun Pharma’s Taro have received the first US Food and Drug Administration approvals for a generic version of Johnson & Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) – a
ScripUS President Donald Trump’s stance on reciprocal tariffs and policy efforts towards reshoring continue to make countries nervous and CEOs of India Pharma Inc, at a recent event, weighed in, signalli